Doi N, Nishio K, Nakatani H, Hayashi T, Miyamoto S, Hashimoto T, Dohi K
Department of Emergency and Critical Care Medicine, Nara Medical University.
J Cardiol. 1999 May;33(5):251-6.
P-selectin, an adhesion molecule, is involved in the alpha-granules of platelets with several factors such as platelet factor 4 (PF-4) and in Weibel-Parade bodies of endothelial cells with von Willebrand factor. The levels of the soluble form of P-selectin increase after angina episodes in patients with unstable angina, indicating that soluble P-selectin is associated with platelet activation and thrombogenesis in the coronary circulation. To evaluate the effect of successful coronary angioplasty on platelet activation or thrombogenesis in the coronary circulation, plasma soluble P-selectin, PF-4 and von Willebrand factor antigen levels were measured in blood obtained from the coronary sinus before and after successful coronary angioplasty in 15 patients with unstable angina. Fifteen patients with normal coronary angiograms served as controls. Plasma P-selectin, PF-4 and von Willebrand factor antigen levels were determined by sandwich enzyme-linked immunosorbent assays. Increased plasma soluble P-selectin (159.7 +/- 74.5 vs 78.7 +/- 26.4 ng/ml, p < 0.01) and PF-4 (456.5 +/- 87.0 vs 118.7 +/- 62.3 IU/ml, p < 0.01) levels were found in patients with unstable angina compared with those in controls, and were significantly decreased after angioplasty (147.8 +/- 69.6 ng/ml, p < 0.05; 401.6 +/- 108.5 IU/ml, p < 0.05), whereas von Willebrand factor antigen was unchanged. The ratio of plasma soluble P-selectin levels after and before angioplasty correlated with the corresponding ratio of plasma PF-4 levels (r = 0.53, p < 0.05), but not with the ratio of plasma von Willebrand factor antigen levels. The plasma levels of soluble P-selectin, which increase in the coronary circulation in patients with unstable angina, decrease after successful coronary angioplasty. Such data indicate that soluble P-selectin is associated with platelet activation and the therapeutical procedure improves the thrombogenic state in the coronary circulation.
P-选择素是一种黏附分子,存在于血小板的α颗粒中,与血小板第4因子(PF-4)等多种因子有关,同时也存在于内皮细胞的魏尔-帕拉德小体中,与血管性血友病因子有关。不稳定型心绞痛患者心绞痛发作后,可溶性P-选择素水平升高,这表明可溶性P-选择素与冠状动脉循环中的血小板活化和血栓形成有关。为了评估成功的冠状动脉血管成形术对冠状动脉循环中血小板活化或血栓形成的影响,对15例不稳定型心绞痛患者成功进行冠状动脉血管成形术前后,从冠状窦采集的血液中血浆可溶性P-选择素、PF-4和血管性血友病因子抗原水平进行了测定。15例冠状动脉造影正常的患者作为对照。采用夹心酶联免疫吸附测定法测定血浆P-选择素、PF-4和血管性血友病因子抗原水平。与对照组相比,不稳定型心绞痛患者血浆可溶性P-选择素(159.7±74.5对78.7±26.4 ng/ml,p<0.01)和PF-4(456.5±87.0对118.7±62.3 IU/ml,p<0.01)水平升高,血管成形术后显著降低(147.8±69.6 ng/ml,p<0.05;401.6±108.5 IU/ml,p<0.05),而血管性血友病因子抗原水平无变化。血管成形术后与术前血浆可溶性P-选择素水平之比与血浆PF-4水平的相应比值相关(r = 0.53,p<0.05),但与血浆血管性血友病因子抗原水平之比无关。不稳定型心绞痛患者冠状动脉循环中升高的可溶性P-选择素血浆水平,在成功的冠状动脉血管成形术后降低。这些数据表明可溶性P-选择素与血小板活化有关,并且治疗过程改善了冠状动脉循环中的血栓形成状态。